Sarah N. Bevins

机构：Life Services (United States) · ORCID：0000-0002-4999-6836

发表论文 95 篇 · 总被引 5609 次 · h-index 32

代表论文

• Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis (2022 · The Lancet · 被引 331)
• H5N1 highly pathogenic avian influenza clade 2.3.4.4b in wild and domestic birds: Introductions into the United States and reassortments, December 2021–April 2022 (2023 · Virology · 被引 235)
• Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial (2023 · The Lancet · 被引 132)
• Transmission of SARS-CoV-2 in free-ranging white-tailed deer in the United States (2023 · Nature Communications · 被引 110)
• Accelerated evolution of SARS-CoV-2 in free-ranging white-tailed deer (2023 · Nature Communications · 被引 71)
• Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial (2023 · The Lancet Diabetes & Endocrinology · 被引 41)